Patents by Inventor Mae Eng

Mae Eng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF COMPROMISED COMPONENTS IN A MEDICAL SYSTEM
    Publication number: 20210322770
    Abstract: In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 21, 2021
    Inventors: Jonathon E. Giftakis, Timothy J. Denison, Paul H. Stypulkowski, Scott R. Stanslaski, Robert S. Raike, Mae Eng, David E. Linde, Thomas Adamski
  • Identification of compromised components in a medical system
    Patent number: 11077305
    Abstract: In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: August 3, 2021
    Assignee: MEDTRONIC, INC.
    Inventors: Jonathon E. Giftakis, Timothy J. Denison, Paul H. Stypulkowski, Scott R. Stanslaski, Robert S. Raike, Mae Eng, David E. Linde, Thomas Adamski
  • IDENTIFICATION OF COMPROMISED COMPONENTS IN A MEDICAL SYSTEM
    Publication number: 20180071530
    Abstract: In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 15, 2018
    Inventors: Jonathon E. Giftakis, Timothy J. Denison, Paul H. Stypulkowski, Scott R. Stanslaski, Robert S. Raike, Mae Eng, David E. Linde, Thomas Adamski